Abstract
For the past 40 years since the observation by Huggins and Hodges that surgical castration or diethylstilbestrol (DES) could bring relief of symptoms from metastatic prostate cancer, these have been the standard therapies for the initial treatment of that disease (1,2). However, during that time the search for less toxic and more acceptable forms of therapy has continued.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Huggins, C. and Hodges, C.V. Studies on prostatic cancer. I.The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1:293–297, 1941.
Huggins, C., Stevens, R.E., Jr. and Hodges, C.V. Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch. Surg.,43:209–223, 1941.
Belchetz, P.E., Plant, T.M., Nakai, Y., Keogh, E.J. andKnobil, E.. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotrophin-releasing hormone. Science 202:631–633, 1978.
Linde, R., Doelle, G.C., Alexander, N., Kirchner, F., Vale, W., Rivier, and J., Rabin, D. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotrophin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. New Eng. J. Med. 305:663–667, 1981.
Ahmed, S.R., Brooman, P.J.C., Shalet, S.M., Howell, A., Blacklock, N.J. and Rickards, D. Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms. Lancet 2:415–419, 1983.
Allen, J.M., O’Shea, J.P., Mashiter, K, Williams, G. and Bloom, S.R. Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing agonist. Br. Med. Journal 286:1607–1609, 1983.
Borgmann, Hardt W., Schmidt-Gollwitzer, M., Adenauer, H. and Nagel, R. Sustained suppression of testosterone production by the luteinizing-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma: a new therapeutic approach? Lancet 1:1097–1099, 1982.
Faure, N., Lemay, A., Laroche, B., et al. Preliminary results on the clinical efficacy and safety of androgen inhibition by the LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma. The Prostate 4:601- 624, 1983.
Garnick, M.B. and Glode, L.M. for the leuprolide Study Group. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. New Engl. J. Med. 311:1281–1286, 1984.
Koutsilieris, M. and Tolis, G. Gonadotrophin-releasing hormone agonist analogues in the treatment of advanced prostatic carcinoma. The Prostate 4:569–577, 1983.
Walker, K.J., Nicholson, R.I., Turkes, A.O., et al. Therapeutic potential of the LHRH agonist, IC 118630, in the treatment of advanced prostatic cancer. Lancet 2:413–415, 1983.
Waxman, J.H., Wass, J.A.H., Henry, W.F., et al. Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. Br. Med. J. 286:1309–1312, 1983.
Schmidt, J.D., Scott, W.W., Gibbons R., et al. Chemotheapy programs of the National Prostatic Cancer Project. Cancer 45:1937–1946, 1980.
Warner, B., Worgul T.J., Drago, J., et al. Effect of very highdose D-luecine -gonadotrophin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer. Clin. Invest. 7:1842–1853, 1983.
Robinson, M.R. and Thomas, B. Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma. Br. J. Med. 4:391–394, 1971.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Garnick, M.B., Swanson, L.J., Max, D.T. (1988). A Randomized Prospective Evaluation of Leuprolide versus Diethylstilbestrol in the Treatment of Stage D2 Metastatic Prostate Cancer: Results of a Multicenter Study. In: Coffey, D.S., Resnick, M.I., Dorr, F.A., Karr, J.P. (eds) A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1667-1_23
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1667-1_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8925-8
Online ISBN: 978-1-4613-1667-1
eBook Packages: Springer Book Archive